Al[<sup>18</sup>F]F-NOTA-Octreotide Is Comparable to [<sup>68</sup>Ga]Ga-DOTA-TATE for PET/CT Imaging of Neuroendocrine Tumours in the Latin-American Population

Al[<sup>18</sup>F]F-NOTA-Octreotide Is Comparable to [<sup>68</sup>Ga]Ga-DOTA-TATE for PET/CT Imaging of Neuroendocrine Tumours in the Latin-American Population

PET imaging of neuroendocrine tumours (NET) is well established for staging and therapy follow-up. The short half-life, increasing costs, and regulatory issues significantly limit the availability of approved imaging agents, such as [<sup>68</sup>Ga]Ga-DOTA-TATE. Al[<sup>18</sup...

Full description

Bibliographic Details
Main Authors: Arlette Haeger, Cristian Soza-Ried, Vasko Kramer, Ana Hurtado de Mendoza, Elisabeth Eppard, Noémie Emmanuel, Johanna Wettlin, Horacio Amaral, René Fernández
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Cancers
Subjects:
neuroendocrine tumours
SSTR
Al[<sup>18</sup>F]F-NOTA-Octreotide
PET imaging
Online Access:https://www.mdpi.com/2072-6694/15/2/439

Similar Items

Similar Items